vilazodone

Home » Classic Medicine » Pharmacology » vilazodone
vilazodone2016-11-15T14:58:20+00:00

vilazodone

PSYCHIATRY, THERAPEUTICS

An agent that is both an SSRI–selective serotonin reuptake inhibitor and a partial 5-HT1A receptor agonist which is FDA-approved for managing major depressive disorder.

Contraindications Concomitant treatment with MAOIs-monoamine oxidase inhibitors, given the risk of serotonin syndrome.

Adverse effects Diarrhoea, nausea, insomnia, vomiting

Proprietary name Viibryd™ 

Reference Product literature, Forest Pharmaceuticals

Leave A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.